These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19019169)

  • 21. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
    Xiao J; Leung JC; Chan LY; Guo H; Lai KN
    Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.
    Sakurai N; Kuroiwa T; Ikeuchi H; Hiramatsu N; Takeuchi S; Tomioka M; Shigehara T; Maeshima A; Kaneko Y; Hiromura K; Kopp JB; Nojima Y
    Nephrol Dial Transplant; 2009 Aug; 24(8):2378-83. PubMed ID: 19188342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT; Palle S; Berthoux F
    Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPARalpha activation upregulates nephrin expression in human embryonic kidney epithelial cells and podocytes by a dual mechanism.
    Ren S; Xin C; Beck KF; Saleem MA; Mathieson P; Pavenstädt H; Pfeilschifter J; Huwiler A
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1818-24. PubMed ID: 16288986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect of mesangial cell-induced CXCL1 and TGF-β1 in promoting podocyte loss in IgA nephropathy.
    Zhu L; Zhang Q; Shi S; Liu L; Lv J; Zhang H
    PLoS One; 2013; 8(8):e73425. PubMed ID: 24023680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of nephrin according to glomerular size in early diabetic kidney disease.
    Kim JJ; Li JJ; Jung DS; Kwak SJ; Ryu DR; Yoo TH; Han SH; Choi HY; Kim HJ; Han DS; Kang SW
    J Am Soc Nephrol; 2007 Aug; 18(8):2303-10. PubMed ID: 17599973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum IgA(1) from patients with IgA nephropathy induces phosphorylation of extracellular signal-regulated kinase and proliferation of human mesangial cells].
    Wang Y; Zhao M; Zhang Y; Li X; Wang H
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1406-9. PubMed ID: 12509924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy.
    Ding JX; Xu LX; Lv JC; Zhao MH; Zhang H; Wang HY
    Clin Immunol; 2007 Dec; 125(3):268-74. PubMed ID: 17913589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy.
    Xiao J; Leung JC; Chan LY; Tang SC; Lai KN
    Clin Immunol; 2009 Aug; 132(2):266-76. PubMed ID: 19443277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Size-dependent binding of IgA to HepG2, U937, and human mesangial cells.
    Leung JC; Tsang AW; Chan LY; Tang SC; Lam MF; Lai KN
    J Lab Clin Med; 2002 Dec; 140(6):398-406. PubMed ID: 12486407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Huangqi Guizhi Wuwu Decoction attenuates Podocyte cytoskeletal protein damage in IgA nephropathy rats by regulating AT1R/Nephrin/c-Abl pathway.
    Liu W; Shi L; Wan Q; Wu Y; Huang D; Ou J; Liu Q; Guan X; Yang Y; Zhang X; Gao J
    Biomed Pharmacother; 2021 Oct; 142():111907. PubMed ID: 34339916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of podocyte injury in IgA nephropathy.
    Menon MC; Chuang PY; He JC
    Contrib Nephrol; 2013; 181():41-51. PubMed ID: 23689566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding capacity of in vitro deglycosylated IgA1 to human mesangial cells.
    Zhang JJ; Xu LX; Zhang Y; Zhao MH
    Clin Immunol; 2006 Apr; 119(1):103-9. PubMed ID: 16442846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC
    Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
    Rüster C; Bondeva T; Franke S; Tanaka N; Yamamoto H; Wolf G
    Am J Nephrol; 2009; 29(6):538-50. PubMed ID: 19129693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
    J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion.
    Zhu X; Shen X; Lin B; Fang J; Jin J; He Q
    Front Pharmacol; 2022; 13():889008. PubMed ID: 35899112
    [No Abstract]   [Full Text] [Related]  

  • 39. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
    Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
    Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compositional similarity between immunoglobulins binding to asialo-, agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy.
    Takatani T; Iwase H; Itoh A; Nakamura I; Hayashi M; Sakamoto H; Kamata K; Kobayashi Y; Hiki Y; Okamoto M; Higashihara M
    J Nephrol; 2004; 17(5):679-86. PubMed ID: 15593035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.